PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with (18)F-AV-133 (florbenazine) in patients with Alzheimer’s disease and Lewy body disorders

BACKGROUND: Biomarkers based on the underlying pathology of Alzheimer’s disease (AD) and Dementia with Lewy Bodies (DLB) have the potential to improve diagnosis and understanding of the substrate for cognitive impairment in these disorders. The objective of this study was to compare the patterns of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Siderowf, Andrew, Pontecorvo, Michael J, Shill, Holly A, Mintun, Mark A, Arora, Anupa, Joshi, Abhinay D, Lu, Ming, Adler, Charles H, Galasko, Douglas, Liebsack, Carolyn, Skovronsky, Daniel M, Sabbagh, Marwan N
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4027995/
https://ncbi.nlm.nih.gov/pubmed/24716655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-14-79
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados